Goldman Sachs Group Inc Lucid Diagnostics Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 86,302 shares of LUCD stock, worth $86,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,302
Previous 86,302
-0.0%
Holding current value
$86,302
Previous $128,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LUCD
# of Institutions
57Shares Held
10.9MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.73 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$1.89 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$1.58 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$888,8740.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$459,0650.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...